Reducing oral steroid intolerability and drug costs for acute wheezers: A retrospective evaluation of a clinical management algorithm in a Pediatric Emergency Department
Pediatric Pulmonology · 2023
DOI: 10.1002/ppul.26286 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pediatric Pulmonology, 2023. Verfasst von Gail Davison und 10 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Medical Education, Queen's University Belfast, Belfast, Northern Ireland, UK. Hauptthemen laut MEDLINE: Asthma. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Project Aim To retrospectively evaluate a clinical management algorithm for acute wheezers in a UK Pediatric Emergency Department (PED). Overview and Rationale Acute wheezing attacks are a leading cause of PED attendances and inpatient admissions. Prednisolone, a routine treatment, is intolerable in almost one‐third of children, requiring repeated dosing, which may prolong length of stay (LOS). To address this problem, we: (1) developed an acute management algorithm (concise, single‐sided flow‐chart, instructing immediate management); (2) modified the OCS regime from prednisolone (1 mg/kg, 3‐day course) to dexamethasone (600 then 300 mcg/kg); (3) and disseminated guidance regionally. Written information—handouts, e‐mails, and posters—were followed‐up with verbal reinforcement. We implemented the algorithm in 2017 and revised it further in 2018. Evaluation In 2019, we retrospectively collected data on 100 acute wheeze attendances (those requiring OCS, aged 2–14), between October and December in 2016, 2017, and 2018 ( n = 300), and assessed outcomes.
Results
Over a 48‐month period, we reduced OCS intolerability by 67.2% and OCS drug costs by 85.8% (saving £41,470.14), while not significantly influencing the other outcomes.
Conclusions
Reduced intolerability and substantial cost savings can be achieved by implementing a structured acute pediatric wheeze algorithm and modifying the OCS to single‐dose dexamethasone (300 mcg/kg).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Centre for Medical Education, Queen's University Belfast, Belfast, Northern Ireland, UK.
- Children's Emergency Department, (primary institution), Royal Belfast Hospital for Sick Children, Belfast, Northern Ireland, UK.
- Pharmacy Department, Royal Belfast Hospital for Sick Children, Belfast, Northern Ireland, UK.
- Respiratory Department, Royal Belfast Hospital for Sick Children, Belfast, Northern Ireland, UK.
- Centre for Experimental Medicine, Queen's University Belfast, Belfast, Northern Ireland, UK.
ORCID-Profile: Gail Davison, Vikki O'Neill, Mike D Shields
Zitieren
APA
Davison, G., Ruddell, J., Trouton, M., McDonald, R., Kennedy, B., O'Neill, V., McCann, J., Bartholome, B., Steen, H., Shields, M. D., & Mullen, S. (2023). Reducing oral steroid intolerability and drug costs for acute wheezers: A retrospective evaluation of a clinical management algorithm in a Pediatric Emergency Department. Pediatric Pulmonology. https://doi.org/10.1002/ppul.26286
Vancouver
Davison G, Ruddell J, Trouton M, McDonald R, Kennedy B, O'Neill V, et al. Reducing oral steroid intolerability and drug costs for acute wheezers: A retrospective evaluation of a clinical management algorithm in a Pediatric Emergency Department. Pediatric Pulmonology. 2023. doi:10.1002/ppul.26286
BibTeX
@article{Davison2023,
author = {Davison, Gail and Ruddell, Josh and Trouton, Michelle and McDonald, Roisin and Kennedy, Ben and O'Neill, Vikki and McCann, Joseph and Bartholome, Brigitte and Steen, Heather and Shields, Mike D and Mullen, Stephen},
title = {Reducing oral steroid intolerability and drug costs for acute wheezers: A retrospective evaluation of a clinical management algorithm in a Pediatric Emergency Department},
journal = {Pediatric Pulmonology},
year = {2023},
doi = {10.1002/ppul.26286}
}
EUVIMED